GO:0051150 regulation of smooth muscle cell differentiation: Phenotypic Switching, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051150 describes any process that modulates the frequency, rate or extent of smooth muscle cell differentiation, a central event in vascular development and disease.
• Smooth muscle cells (SMCs) retain remarkable plasticity; they can switch between a contractile, differentiated state and a synthetic, proliferative state in response to injury or disease.
• Key transcription factors such as myocardin (MYOCD), serum response factor (SRF), and Kruppel-like factors orchestrate the contractile gene program that defines differentiated SMCs.
• Epigenetic mechanisms, including DNA methylation and histone modifications, regulate SMC differentiation and phenotypic switching.
• Dysregulated SMC differentiation contributes to atherosclerosis, intimal hyperplasia, and restenosis, making this process a therapeutic target.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of genes regulating SMC differentiation.
Description
The Gene Ontology term GO:0051150, regulation of smooth muscle cell differentiation, encompasses any process that modulates the frequency, rate or extent of smooth muscle cell differentiation. Smooth muscle cells (SMCs) are essential components of blood vessels, the gastrointestinal tract, and other organs, where they perform contractile and synthetic functions. Unlike terminally differentiated skeletal muscle cells, SMCs retain remarkable plasticity and can reversibly modulate their phenotype in response to environmental cues, a phenomenon known as phenotypic switching. This plasticity is critical during development, but its dysregulation underlies major human diseases including atherosclerosis, hypertension, and restenosis after angioplasty. Understanding how SMC differentiation is regulated at the transcriptional and epigenetic levels is therefore of broad biomedical importance. Recent advances in single-cell genomics have revealed novel SMC states and intermediate phenotypes during phenotypic switching, providing new insights into the regulatory networks that control differentiation. Moreover, circular RNAs and microRNAs have emerged as important post-transcriptional regulators of SMC differentiation, offering potential therapeutic targets. This article synthesizes current knowledge on the regulation of SMC differentiation, highlighting key genes, mechanisms, disease relevance, and research methodologies including CRISPR-based approaches.
regulation of smooth muscle cell differentiation At A Glance
| GO ID | GO:0051150 |
|---|---|
| GO term | regulation of smooth muscle cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of smooth muscle cell differentiation |
| Related process | Smooth muscle cell phenotypic switching and contractile gene expression |
| Key regulators | MYOCD, SRF, KLF4, KLF5, TET2, and microRNAs |
| Disease relevance | Atherosclerosis, intimal hyperplasia, restenosis, hypertension |
| Research methods | Single-cell RNA-seq, ChIP-seq, CRISPR screens, epigenetic profiling |
What Is GO:0051150?
According to the Gene Ontology, GO:0051150 (regulation of smooth muscle cell differentiation) is defined as any process that modulates the frequency, rate or extent of smooth muscle cell differentiation. In other words, it includes all molecular and cellular events that control whether, when, and how efficiently a smooth muscle cell acquires its specialized, contractile phenotype. This regulation can occur at transcriptional, post-transcriptional, epigenetic, and signaling levels, and it is essential for vascular development and homeostasis.
Why Is regulation of smooth muscle cell differentiation Important in Cell Biology?
Regulation of smooth muscle cell differentiation is fundamental to vascular biology and human health. SMCs are the predominant cell type in the arterial wall, and their ability to switch between contractile and synthetic phenotypes is critical for vascular remodeling and repair. However, when this regulation goes awry, it contributes to the pathogenesis of atherosclerosis, restenosis, and other cardiovascular diseases. Understanding the molecular mechanisms that control SMC differentiation is therefore essential for developing targeted therapies to modulate SMC behavior in disease.
• SMC differentiation is essential for normal blood vessel development and function.
• Phenotypic switching of SMCs contributes to atherosclerosis and restenosis.
• Transcription factors like MYOCD and SRF are master regulators of the contractile SMC program.
• Epigenetic modifications, including DNA methylation and histone acetylation, regulate SMC differentiation.
• MicroRNAs and circular RNAs modulate SMC differentiation post-transcriptionally.
• Dysregulated SMC differentiation is implicated in hypertension and vascular aging.
• Single-cell genomics has revealed novel SMC states during phenotypic switching.
• CRISPR-based gene editing enables functional dissection of SMC differentiation regulators.
• SMC differentiation is a potential therapeutic target for vascular diseases.
• In vitro models using iPS cells and nanofibers facilitate study of SMC differentiation.
What Happens During regulation of smooth muscle cell differentiation?
Transcriptional control of the contractile gene program
In simple terms: Master transcription factors turn on the genes that make a smooth muscle cell contractile.
The differentiation of smooth muscle cells is driven by a network of transcription factors that activate contractile genes such as ACTA2, MYH11, and CNN1. Myocardin (MYOCD) is a potent coactivator of serum response factor (SRF) that synergistically activates CArG box-containing promoters of SMC contractile genes. Kruppel-like factor 4 (KLF4) and KLF5 can repress this program, promoting a synthetic phenotype. The balance between activating and repressive transcription factors determines the differentiation state of SMCs.
Epigenetic regulation of SMC differentiation
In simple terms: Chemical tags on DNA and histones can lock genes in an on or off state, controlling smooth muscle cell identity.
Epigenetic mechanisms, including DNA methylation and histone modifications, play critical roles in regulating SMC differentiation. For example, the ten-eleven translocation (TET) enzyme TET2 promotes DNA demethylation and activates SMC contractile gene expression. Histone acetyltransferases and deacetylases modulate chromatin accessibility at SMC gene loci, thereby influencing differentiation. These epigenetic marks provide a layer of regulation that stabilizes the differentiated state and can be reversed during phenotypic switching.
Post-transcriptional and non-coding RNA regulation
In simple terms: Small RNA molecules and circular RNAs can fine-tune the levels of proteins that control smooth muscle cell differentiation.
MicroRNAs (miRNAs) and circular RNAs (circRNAs) regulate SMC differentiation post-transcriptionally. For instance, circMAP3K5 acts as a sponge for miR-22-3p, thereby promoting TET2 expression and enhancing SMC differentiation. Other miRNAs, such as miR-143/145, are known to promote the contractile phenotype. These non-coding RNAs provide additional layers of control and represent potential therapeutic targets.
Signaling pathways and environmental cues
In simple terms: Signals from outside the cell, like growth factors and mechanical forces, tell smooth muscle cells whether to differentiate or proliferate.
Extracellular signals, including TGF-beta, PDGF, and mechanical stretch, modulate SMC differentiation through intracellular signaling cascades. TGF-beta signaling promotes the contractile phenotype via Smad-dependent activation of MYOCD and SRF. In contrast, PDGF-BB and inflammatory cytokines drive phenotypic switching toward a synthetic, proliferative state. These signaling pathways integrate with transcriptional and epigenetic regulators to fine-tune SMC differentiation in response to environmental demands.
Phenotypic switching and cellular plasticity
In simple terms: Smooth muscle cells can change their identity back and forth, which is important for repair but can also cause disease.
SMCs exhibit remarkable plasticity, transitioning between contractile and synthetic states in response to injury or disease. Single-cell genomics has identified intermediate cell states during this switching process, revealing novel markers and potential therapeutic targets. Premature cell senescence can promote phenotypic modulation and resistance to re-differentiation, contributing to vascular pathology. Understanding the regulatory mechanisms of phenotypic switching is key to developing interventions that preserve or restore the contractile phenotype.
Key Genes Involved in GO:0051150 regulation of smooth muscle cell differentiation
The following genes and proteins are central to the regulation of smooth muscle cell differentiation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYOCD | Master coactivator of SRF; activates contractile gene program | Key regulator of SMC differentiation; target for modulating phenotype |
| SRF | Transcription factor binding CArG boxes; partners with MYOCD | Central node in SMC contractile gene expression |
| KLF4 | Represses SMC contractile genes; promotes synthetic phenotype | Modulates phenotypic switching in atherosclerosis |
| KLF5 | Regulates SMC proliferation and differentiation | Implicated in vascular remodeling |
| TET2 | DNA demethylase; promotes SMC contractile gene expression | Mediates circMAP3K5/miR-22-3p effects on SMC differentiation |
| ACTA2 | Smooth muscle alpha-actin; contractile protein | Marker of differentiated SMCs |
| MYH11 | Smooth muscle myosin heavy chain; contractile protein | Marker of differentiated SMCs |
| CNN1 | Calponin; contractile protein | Marker of differentiated SMCs |
| miR-143/145 | Promote contractile phenotype | Regulate SMC differentiation and vascular tone |
| miR-22-3p | Targets TET2; inhibits SMC differentiation | Sponged by circMAP3K5; therapeutic target |
| circMAP3K5 | Circular RNA; sponges miR-22-3p to promote TET2 | Promotes SMC differentiation and resolution of intimal hyperplasia |
| PDGF-BB | Growth factor; promotes synthetic phenotype | Drives phenotypic switching in vascular disease |
| TGF-beta | Cytokine; promotes contractile phenotype | Induces SMC differentiation via Smad signaling |
| Notch | Signaling pathway; regulates SMC differentiation | Involved in vascular development |
| Ets-1 | Transcription factor; represses SMC contractile genes | Modulates phenotypic switching |
| Sp1 | Transcription factor; regulates SMC gene expression | Cooperates with SRF/MYOCD |
| FoxO4 | Transcription factor; regulates SMC differentiation and proliferation | Implicated in vascular remodeling |
How Is regulation of smooth muscle cell differentiation Regulated?
The regulation of smooth muscle cell differentiation is controlled by a complex interplay of transcriptional, epigenetic, and signaling mechanisms. Key signaling pathways include TGF-beta, which promotes differentiation via Smad2/3 and MYOCD, and PDGF-BB, which drives dedifferentiation through ERK and KLF4. Epigenetic regulators such as TET2 and histone deacetylases modulate chromatin accessibility at contractile gene loci. Additionally, microRNAs like miR-143/145 and miR-22-3p fine-tune the expression of differentiation-associated genes. Cellular senescence has also been shown to promote phenotypic modulation and resistance to re-differentiation, adding another layer of regulation.
regulation of smooth muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYOCD | Atherosclerosis; loss of contractile phenotype | Knockout mouse; SMC-specific conditional KO |
| TET2 | Intimal hyperplasia; impaired SMC differentiation | Overexpression and knockout in SMC cultures |
| KLF4 | Atherosclerosis; promotes synthetic phenotype | Inducible SMC-specific knockout |
| circMAP3K5 | Intimal hyperplasia; regulates miR-22-3p/TET2 axis | Overexpression in balloon injury model |
| ACTA2 | Vascular disease; marker of differentiated SMCs | Reporter knock-in mice |
Atherosclerosis and phenotypic switching
Dysregulated SMC differentiation is a hallmark of atherosclerosis. In response to lipid accumulation and inflammation, SMCs switch from a contractile to a synthetic phenotype, migrate into the intima, and contribute to plaque formation. Single-cell studies have identified a novel SMC-derived cell state in atherosclerotic plaques that may represent a therapeutic target. Modulating SMC differentiation could stabilize plaques and reduce cardiovascular events.
Intimal hyperplasia and restenosis
After vascular injury such as angioplasty, SMCs dedifferentiate, proliferate, and migrate, leading to intimal hyperplasia and restenosis. CircMAP3K5 has been shown to promote SMC differentiation and resolve intimal hyperplasia via TET2-mediated mechanisms, suggesting a potential therapeutic strategy. Understanding the regulation of SMC differentiation is therefore critical for preventing restenosis.
Vascular aging and senescence
Premature cell senescence promotes SMC phenotypic modulation and resistance to re-differentiation, contributing to vascular aging and disease. Senescent SMCs exhibit reduced expression of contractile markers and increased inflammatory secretion, which can exacerbate vascular pathology. Targeting senescence pathways may help restore SMC differentiation and improve vascular health.
From regulation of smooth muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate SMC differentiation? | CRISPR knockout in primary SMCs or iPS-derived SMCs |
| Does a point mutation in gene X affect SMC contractile function? | CRISPR point mutation knock-in in SMC lines |
| Does overexpression of gene X promote differentiation? | Lentiviral overexpression in SMCs |
| Does a tagged version of protein X localize correctly? | CRISPR knock-in of fluorescent tag |
| What is the effect of gene X on SMC phenotypic switching? | Single-cell RNA-seq after CRISPR perturbation |
| Can gene X rescue differentiation in senescent SMCs? | CRISPR activation or overexpression in senescent cells |
How to Study the regulation of smooth muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| scRNA-seq | Transcriptomes of individual cells | Identify SMC states during phenotypic switching |
| ATAC-seq | Chromatin accessibility | Map regulatory regions of SMC genes |
| ChIP-seq | Histone modifications and TF binding | Study epigenetic regulation of SMC differentiation |
| Bisulfite sequencing | DNA methylation | Assess TET2-mediated demethylation |
| CRISPR knockout screen | Gene function loss | Discover regulators of SMC differentiation |
| CRISPR activation screen | Gene overexpression | Identify drivers of SMC differentiation |
| iPSC differentiation | SMC contractile phenotype | Model SMC differentiation in vitro |
| Balloon injury model | Intimal hyperplasia | Test circMAP3K5 effects on SMC differentiation |
Single-cell genomics
Single-cell RNA sequencing (scRNA-seq) has been instrumental in revealing novel SMC states and intermediate phenotypes during phenotypic switching. This method allows researchers to dissect heterogeneity within SMC populations and identify rare cell states that may be missed by bulk analysis. Combining scRNA-seq with lineage tracing can uncover the origins and fates of modulated SMCs in disease.
Epigenetic profiling
Assays such as ATAC-seq, ChIP-seq, and bisulfite sequencing measure chromatin accessibility, histone modifications, and DNA methylation at SMC gene loci. These techniques help define how epigenetic changes regulate SMC differentiation and phenotypic switching. For example, TET2-mediated DNA demethylation can be tracked using bisulfite sequencing.
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify novel regulators of SMC differentiation. By coupling CRISPR perturbations with differentiation markers (e.g., ACTA2 expression), researchers can systematically discover genes that promote or inhibit the contractile phenotype. These screens are particularly powerful when combined with single-cell readouts.
In vitro differentiation models
Induced pluripotent stem cells (iPSCs) can be differentiated into SMCs using defined factors and substrates, such as curcumin-incorporated nanofibers. These models provide a controlled system to study the regulation of SMC differentiation and to test the effects of genetic perturbations. They also enable the production of patient-specific SMCs for disease modeling.
How CRISPR Can Be Used to Study GO:0051150 regulation of smooth muscle cell differentiation
Knockout
CRISPR knockout of candidate genes in SMCs or iPSC-derived SMCs can reveal whether a gene is necessary for differentiation. For example, knocking out TET2 would impair SMC contractile gene expression. Knockout models are essential for establishing causality in SMC differentiation research.
Point Mutation
CRISPR point mutation knock-in allows the study of specific amino acid changes in proteins that regulate SMC differentiation. This is useful for modeling human genetic variants associated with vascular diseases. For instance, mutations in MYOCD or SRF could be introduced to test their effects on contractile gene activation.
Knock-in
CRISPR knock-in of reporter genes (e.g., fluorescent proteins) or tags into endogenous loci enables real-time tracking of SMC differentiation markers like ACTA2. Tagged knock-in of transcription factors can also facilitate ChIP-seq or imaging studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high-level expression of genes like MYOCD or TET2 to promote SMC differentiation. Overexpression models are useful for gain-of-function studies and for testing therapeutic candidates.
How EDITGENE Supports regulation of smooth muscle cell differentiation Research
Researchers studying regulation of smooth muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in the contractile phenotype, phenotypic switching, or disease progression. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for regulation of smooth muscle cell differentiation research.
Frequently Asked Questions About regulation of smooth muscle cell differentiation
What is GO:0051150?
GO:0051150 is the Gene Ontology term for regulation of smooth muscle cell differentiation, defined as any process that modulates the frequency, rate or extent of smooth muscle cell differentiation.
What genes are involved in regulation of smooth muscle cell differentiation?
Key genes include MYOCD, SRF, KLF4, KLF5, TET2, ACTA2, MYH11, and CNN1, as well as non-coding RNAs like miR-143/145 and circMAP3K5.
How is smooth muscle cell differentiation regulated?
It is regulated at transcriptional, epigenetic, and post-transcriptional levels by factors such as MYOCD, SRF, TET2, and microRNAs, as well as signaling pathways like TGF-beta and PDGF.
What diseases are associated with dysregulated smooth muscle cell differentiation?
Atherosclerosis, intimal hyperplasia, restenosis, and vascular aging are linked to abnormal SMC differentiation.
What is smooth muscle cell phenotypic switching?
Phenotypic switching is the reversible transition of SMCs between contractile and synthetic states, which is critical in vascular disease.
How can CRISPR be used to study smooth muscle cell differentiation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in SMC differentiation.
What are the markers of differentiated smooth muscle cells?
Common markers include ACTA2, MYH11, and CNN1, which are contractile proteins expressed in differentiated SMCs.
What is the role of TET2 in smooth muscle cell differentiation?
TET2 is a DNA demethylase that promotes SMC contractile gene expression and is regulated by circMAP3K5/miR-22-3p.
How does single-cell RNA-seq help study SMC differentiation?
It reveals novel SMC states and intermediate phenotypes during phenotypic switching, identifying potential therapeutic targets.
What in vitro models are used for SMC differentiation research?
iPSC-derived SMCs, primary SMC cultures, and nanofiber-based differentiation systems are commonly used.
Conclusion
Regulation of smooth muscle cell differentiation (GO:0051150) is a fundamental biological process with profound implications for vascular health and disease. The interplay of transcription factors, epigenetic modifiers, and non-coding RNAs determines whether SMCs adopt a contractile or synthetic phenotype, and dysregulation of this balance contributes to atherosclerosis, restenosis, and vascular aging. Advances in single-cell genomics and CRISPR-based editing are accelerating the discovery of new regulators and therapeutic targets. Continued research into the mechanisms governing SMC differentiation will be essential for developing strategies to modulate SMC behavior in cardiovascular disease.
References
- 1. Owens GK et al.. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease.. Physiol Rev 84(3):767-801 PMID: 15269336
- 2. Pan H et al.. 2020. Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human.. Circulation 142(21):2060-2075 PMID: 32962412
- 3. Khachigian LM et al.. 2022. Transcriptional regulation of vascular smooth muscle cell proliferation, differentiation and senescence: Novel targets for therapy.. Vascul Pharmacol 146:107091 PMID: 35896140
- 4. Rzucidlo EM et al.. 2007. Regulation of vascular smooth muscle cell differentiation.. J Vasc Surg 45 Suppl A:A25-32 PMID: 17544021
- 5. Kaistha A et al.. 2025. Premature cell senescence promotes vascular smooth muscle cell phenotypic modulation and resistance to re-differentiation.. Cardiovasc Res 121(9):1448-1463 PMID: 40493738
- 6. Liu R et al.. 2015. Epigenetic regulation of smooth muscle cell plasticity.. Biochim Biophys Acta 1849(4):448-53 PMID: 24937434
- 7. Mokhames Z et al.. 2020. Efficient smooth muscle cell differentiation of iPS cells on curcumin-incorporated chitosan/collagen/polyvinyl-alcohol nanofibers.. In Vitro Cell Dev Biol Anim 56(4):313-321 PMID: 32307668
- 8. Zeng Z et al.. 2021. Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation.. Circulation 143(4):354-371 PMID: 33207953
